PhaseRx is developing a portfolio of mRNA products to treat children with life-threatening inherited liver diseases.
Promosome was founded in 2003 to commercialize discoveries at The Scripps Research Institute by the late Nobel Laureate Dr. Gerald Edelman and his colleague Dr. Vincent Mauro, now Chief Scientific ...
Developing RNA-based therapeutics for rare diseases.
RAPiD GENOMICS offers customized, innovative genetic and genomic solutions for your unique applications.
Ribometrix is a platform therapeutics company discovering small molecule drugs that target functional 3D RNA structures to treat human diseases.
RTLGenomics is a full service sequencing company offering sequencing approaches including barcoding, metagenomics and transcriptomics. A sister lab, MicroGen, is a CAP accredited clinical ...
Use RNA and a protein interaction database to predict drug response.
Seqll specializes in True Single Molecule Sequencing, DNA and RNA.
Designing of small molecules that target the RNA splicing process.
Develops Non-chaotropic chemistry, a chemical process that does not disrupt or denature the structure of macromolecules, such as proteins and nucleic acids. Ions are ranked in the so-called ...
Thera Neuropharma investigates the use of small molecules and RNA-based compounds as therapeutics to treat Amyotrophic Lateral Sclerosis (ALS) and Traumatic Brain Injury (TBI).
Translate Bio is pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating diseases.
Twentyeight-Seven Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases.